Envision Healthcare
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Envision Healthcare generated cash of $797,400,000, which is more than the previous year. Cash used in financing activities reached the amount of $205,300,000 last year. Net change in cash is therefore -$19,400,000.
Cash Flow
| 2013 | 332.82M | -98.73M | -229.64M |
|---|---|---|---|
| 2014 | 412.37M | -2.22B | 1.97B |
| 2015 | 537.95M | -1.01B | 377.44M |
| 2016 | 419.8M | -303.7M | 108.8M |
| 2017 | 797.4M | -982.1M | 205.3M |
EVHC Cash Flow Statement (2013 – 2017)
| 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|
Cash at beginning of period | 331.6M | 106.7M | 208.07M | 50.84M | 46.39M |
Operating activities | |||||
Net income | -26M | 205.5M | 381.11M | 244.79M | 261.54M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 434M | 149.9M | 97.49M | 60.34M | 33.02M |
Stock-based compensation expense | 48.7M | 29.4M | 15.00M | 10.10M | 8.32M |
| Deferred income tax benefit | 48.7M | 29.4M | 15.00M | 10.10M | 8.32M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -5.45B | -1.00B | -326.23M | -137.66M | -1.29M |
Inventories | 1M | -900K | -342K | -206K | 132K |
Accounts payable | -12.1M | -1.6M | 3.13M | -8.44M | 441K |
Cash generated by operating activities | 797.4M | 419.8M | 537.95M | 412.37M | 332.82M |
Investing activities | |||||
Purchases Of Investments | -24.5M | -1.6M | -3.98M | -6.47M | 0 |
Investments In Property Plant And Equipment | -208.9M | -99.5M | -60.30M | -40.21M | -28.85M |
Acquisitions Net | -757.8M | -394.3M | -955.57M | -2.17B | -70.04M |
Cash generated by investing activities | -982.1M | -303.7M | -1.01B | -2.22B | -98.73M |
Financing activities | |||||
Common Stock Issued | 0 | 0 | 466.77M | 439.87M | 33.34M |
Payments for dividends | 0 | 0 | 0 | -4.50M | -162.20M |
Repurchases of common stock | -9.5M | -6.1M | -3.68M | -4.61M | -45.96M |
Repayments of term debt | 460.2M | -4.06B | 167.54M | -408.47M | -202.08M |
Cash used in financing activities | 205.3M | 108.8M | 377.44M | 1.97B | -229.64M |
Net Change In Cash | -19.4M | 224.9M | -101.41M | 157.23M | 4.44M |
Cash at end of period | 312.2M | 331.6M | 106.66M | 208.07M | 50.84M |